Article Versions Notes

Kotańska M, Dziubina A, Szafarz M, Mika K, Bednarski M, Nicosia N, Temirak A, Müller CE, Kieć-Kononowicz K. Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice. International Journal of Molecular Sciences. 2022; 23(21):13439. https://doi.org/10.3390/ijms232113439

Kotańska, Magdalena, Anna Dziubina, Małgorzata Szafarz, Kamil Mika, Marek Bednarski, Noemi Nicosia, Ahmed Temirak, Christa E. Müller, and Katarzyna Kieć-Kononowicz. 2022. "Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice" International Journal of Molecular Sciences 23, no. 21: 13439. https://doi.org/10.3390/ijms232113439

Kotańska, M., Dziubina, A., Szafarz, M., Mika, K., Bednarski, M., Nicosia, N., Temirak, A., Müller, C. E., & Kieć-Kononowicz, K. (2022). Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice. International Journal of Molecular Sciences, 23(21), 13439. https://doi.org/10.3390/ijms232113439